Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

NCT06335914 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT06335914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06335914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
April 3, 2025
Completion date
September 4, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate cancer